images: lawyersandsettlements.com Washington, DC: It's all over the television now—ads for Chantix that depict a smiling, real-life Chantix user going about her everyday business without a cigarette between her fingers, while the announcer rattles off a warning about potential Chantix side effects, including suicide and aggression. Chantix side effects,...

Nabi Biopharmaceuticals and GlaxoSmithKline team up to produce nicotine vaccine and help smokers kick the habit… Anyone who’s ever been a smoker knows just how hard it is to quit. But thanks to a new vaccine that blocks the nicotine in tobacco from entering the brain, quitting could get soon get a lot easier.

NicVAX® (Nicotine Conjugate Vaccine) is an investigational vaccine designed as an aid to smoking cessation, as well as an aid to prevent relapses of a treated smoker NicVAX represents an extension of our conjugate vaccine technology that allows us to address a significant medical need. We believe that broad commercialization of NicVAX will be in conjunction...

Cigarette smoke contains 4000 harmful chemicals. 60 of them are carcinogens. Nicotine is the addictive element in the cigarette smoke. The National Institute of Drug Abuse is developing the nicotine vaccine to counteract the additive effect of nicotine. This article tries to gain further insight in to the findings.

Nicotine Vaccine is tested in clinical trials could move on to FDA approval A new vaccine is beginning clinical trials which may help smokers kick their nicotine habit for good. The National Institute on Drug Abuse recently gave Nabi BioPharmaceuticals a $10 million grant to advance NicVAX, the vaccine designed to help people quit smoking, to clinical...